Spectral AI (MDAI) Expected to Announce Earnings on Tuesday

Spectral AI (NASDAQ:MDAI) is projected to release its Q3 2025 results after the market closes on Tuesday, November 11th. Analysts expect Spectral AI to post earnings of ($0.08) per share and revenue of $5.0620 million for the quarter. Spectral AI has set its FY 2025 guidance at EPS.Investors are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Tuesday, November 11, 2025 at 5:00 PM ET.

Spectral AI (NASDAQ:MDAI) last released its earnings results on Tuesday, August 12th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.03). The business had revenue of $5.07 million during the quarter, compared to the consensus estimate of $5.44 million. On average, analysts expect Spectral AI to post $0 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Spectral AI Stock Performance

Shares of MDAI stock opened at $1.94 on Friday. The stock has a 50 day simple moving average of $2.17 and a 200-day simple moving average of $2.08. The company has a market cap of $53.58 million, a price-to-earnings ratio of -2.81 and a beta of 0.91. Spectral AI has a 12-month low of $1.01 and a 12-month high of $3.25.

Institutional Trading of Spectral AI

Several large investors have recently modified their holdings of the business. Jane Street Group LLC purchased a new position in shares of Spectral AI during the 2nd quarter worth approximately $74,000. Marshall Wace LLP purchased a new position in Spectral AI during the second quarter worth $104,000. XTX Topco Ltd purchased a new position in Spectral AI during the second quarter worth $123,000. Finally, Geode Capital Management LLC raised its holdings in shares of Spectral AI by 21.8% in the second quarter. Geode Capital Management LLC now owns 152,958 shares of the company’s stock worth $379,000 after acquiring an additional 27,365 shares during the last quarter. 67.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on MDAI shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Spectral AI in a research report on Friday, October 31st. Wall Street Zen cut shares of Spectral AI from a “hold” rating to a “strong sell” rating in a research note on Saturday, August 16th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, Spectral AI currently has a consensus rating of “Hold” and an average price target of $3.50.

Spectral AI Company Profile

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.